Cargando…
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
The severe acute respiratory syndrome coronavirus−2 (SARS-CoV-2) has been recently identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 (COVID-19) in China. Now declared a public health emergency, this pandemic is present in more than 200 countries with over 14...
Autores principales: | Johnson, Kemmian D., Harris, Christen, Cain, John K., Hummer, Cicily, Goyal, Hemant, Perisetti, Abhilash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438449/ https://www.ncbi.nlm.nih.gov/pubmed/32903492 http://dx.doi.org/10.3389/fmed.2020.00526 |
Ejemplares similares
-
Gastrointestinal Endoscopy in the Era of COVID-19
por: Perisetti, Abhilash, et al.
Publicado: (2020) -
Clinical Insights into the Gastrointestinal Manifestations of COVID-19
por: Kopel, Jonathan, et al.
Publicado: (2020) -
Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19
por: Perisetti, Abhilash, et al.
Publicado: (2020) -
COVID-19: Pulmonary and Extra Pulmonary Manifestations
por: Elrobaa, Islam H., et al.
Publicado: (2021) -
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
por: Boregowda, Umesha, et al.
Publicado: (2020)